Related Experiment Video
Updated: May 23, 2026

04:19
Robotic Enucleation of Esophageal Leiomyoma
Published on: February 20, 2026
Mesh erosion in robotic sacrocolpopexy
Blake C Osmundsen1, Amanda Clark, Crystal Goldsmith
1Oregon Health & Science University, Portland, OR, USA. Blake.Osmundsen@Providence.org
Female Pelvic Medicine & Reconstructive Surgery
|March 29, 2012
Summary
Supracervical hysterectomy (SH) showed no mesh erosion after robotic sacrocolpopexy. Total hysterectomy (TH) mesh erosion occurred, potentially linked to graft material, warranting further study.
Area of Science:
- Urogynecology
- Minimally Invasive Surgery
- Pelvic Reconstructive Surgery
Background:
- Robotic sacrocolpopexy is a surgical procedure to treat pelvic organ prolapse.
- Hysterectomy, the removal of the uterus, can be performed as a total hysterectomy (TH) or supracervical hysterectomy (SH).
- Mesh erosion is a known complication following sacrocolpopexy.
Purpose of the Study:
- To compare the incidence of mesh erosion after robotic sacrocolpopexy in women who underwent either total hysterectomy (TH) or supracervical hysterectomy (SH).
Main Methods:
- Retrospective cohort study involving 102 women undergoing robotic sacrocolpopexy and concomitant hysterectomy (May 2007-December 2010).
- Primary outcome: mesh erosion identified within 3 months post-surgery.
- Data collected included patient demographics, surgical details, and follow-up outcomes.
Main Results:
- Mesh erosion occurred in 8 women (all with TH), with an incidence of 14% in the TH group versus 0% in the SH group.
- Mesh erosion rates varied significantly between two surgical sites (37% vs. 3%), correlating with mesh type (self-cut vs. precut polypropylene).
- Two women in the SH group were diagnosed with abnormal uterine pathology.
Conclusions:
- Supracervical hysterectomy (SH) was associated with no mesh erosion within the first 3 months post-robotic sacrocolpopexy.
- Graft material may be a modifiable factor influencing mesh erosion in total hysterectomy (TH).
- Further investigation, including longer-term follow-up and randomized trials, is warranted. Abnormal uterine pathology is a possibility with SH.

